Hydration Room, a Southern California-based chain of IV and injection therapy clinics, opened a new location in Los Gatos as ...

OPDIVO is a prescription medicine used in combination with YERVOY as a first treatment to treat adults with cancer of the ...

Learn how subcutaneous nivolumab shifts immunotherapy from IV infusions to quick thigh or abdominal injections, approved in late 2024.

A phase 3 trial of patients with moderate-to-severe TED has shown that subcutaneous injection of Tepezza by way of an on-body ...

Nurse Practitioner Jenna Moses is opening her new health and wellness business, Graceful Health, in Indianapolis on April 11, ...

Deaths in Mexico put spotlight on vitamin IV industry growing in Arizona. What’s really in your vitamin drip? Experts urge ...

Amgen (NASDAQ: AMGN) today announced positive topline results from a Phase 3 trial of TEPEZZA (teprotumumab-trbw) administered by subcutaneous injection via an on-body injector (OBI) in participants ...

Evidence gaps include limited topline safety granularity, unknown long-term follow-up and retreatment rates, and lack of ...

Amgen's Tepezza became the first drug approved by the FDA for thyroid eye disease (TED) in 2020, and the company is now looking to extend its role with a new, more patient-friendly formulation. The ...

The findings could help Amgen defend Tepezza’s market-leading position against emerging rivals, though some analysts ...

The Tennessee Supreme Court has temporarily blocked a lower court’s order that would have let media witnesses view more parts ...

Analysts noted that while TEPEZZA OBI showed stronger efficacy data, Viridian’s elegrobart offers greater convenience with ...